In a recent public notice, the Drug Controller General of India (DCGI) announced a new initiative aimed at enhancing the ease of doing business in India.
Mumbai (Maharashtra) [India], January 3: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, global pharmaceutical company, has launched a biosimilar of the popular 10,11 anti-diabetic drug, Liraglutide, for the first time in India. The drug is being marketed under the brand name Liraf
The National Human Rights Commission (NHRC) sent notices to the Delhi Chief Secretary, Drugs Controller General of India, and Police Commissioner on Friday after the epilepsy drug 'Sodium Valproate' failed a quality test.
Union Health Minister Mansukh Mandaviya has directed the Drugs Controller General of India (DCGI) to take stringent actions against those pharmaceutical manufacturing companies that make spurious drugs.
Ahmedabad (Gujarat) [India], June 29: Intas Pharmaceuticals Ltd., one of India's leading pharmaceutical companies with operations across the globe has launched TOFATAS - a DCGI-approved, Tofacitinib Ointment 2 per cent w/w for the treatment of mild to moderate Atopic Dermatitis (AD) in patie
The mRNA-based booster vaccine GEMCOVAC®-OM, developed to provide immunity against the Omicron variant of Covid-19, has received approval from the regulator Drug Control General of India (DCGI) for emergency use.
AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, on Wednesday announced that it has received approval from the Drug Controller General of India (DCGI) for the cancer drug Trastuzumab Deruxtecan for the treatment of metastatic breast cancer.
The Government of India has cancelled the licenses of 18 pharma companies for manufacturing spurious medicines following an inspection by the Drugs Controller General of India (DCGI) on 76 companies across 20 states, sources said on Thursday.
The Union Health Minister Mansukh Mandaviya will hold a meeting with representatives of E pharmacies soon as these e- pharmacies are on the government's radar, said official sources on Wednesday.
The samples of eye-drops manufactured by India's Global Pharma Healthcare,which were linked to three deaths and blindness in some patients in US, are found to be "free of contamination", said Health Ministry sources on Tuesday.
The Union Ministry of Health is mulling shutting down digital pharmacies due to some concerns like misuse of data, Antimicrobial Resistance (AMR) and predatory pricing of medicines. In the latest development in this regard, FICCI has written a letter to the Drugs Controller General of Ind